GlassScriptPhysician profile
Richard C Mather
NPI 1598923609
$711,204.15
in general payments reported to CMS, 2019-2025
5 companies · $121K in 2025
The $121K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110K · 2020: $45K · 2021: $92K · 2022: $106K · 2023: $109K · 2024: $128K · 2025: $121K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $167K · Royalty Or License: $162K · Travel and Lodging: $25K · Food and Beverage: $4,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $167,012.50 |
| Royalty Or License | $162,143.49 |
| Travel and Lodging | $25,093.49 |
| Food and Beverage | $4,121.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $701,942.44 | 2019-2025 | Na, Insignia, Mild Device Kit |
| Smith+Nephew, INC. | $7,174.79 | 2019-2020 | |
| Rti Surgical, INC | $2,000.00 | 2021 | |
| Osteocentric Technologies, INC. | $86.92 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.